Term
Definition of local anesthetics |
|
Definition
analgesia close to the source of the pain |
|
|
Term
|
Definition
- mechanical
- chemical (acids)
- thermal (extreme temp.)
|
|
|
Term
Mechanism of action of nociceptors |
|
Definition
- activation of sodium channels
- if reach threshold, more sodium channels open
- eventually, acitivate calcium channels activate and calcium into cell
|
|
|
Term
Difference between A delta fibers and C fibers |
|
Definition
- C fibers
- unmyelinated (slower)
- mediate aching pain
- main NT: substance P (also back propagate, mediate recruitment of more histamine, and getting more vasodilation)
- A delta fibers
- myelinated (faster)
- mediate sharp stinging pain'
- main NT: glutamate
|
|
|
Term
Drugs that can alleviate fast pain and slow pain |
|
Definition
- fast pain: local anesthetics
- slow pain: local anesthetics, NSAIDS
- NSAIDS prevent exacerbation of pain response (decrease cyclooxgenase, so decrease PG's)
|
|
|
Term
Mechanism of action of TTX |
|
Definition
- extracellular blocking of voltage gated sodium channels
|
|
|
Term
mechanism of action of local anesthetics |
|
Definition
- when voltage gated sodium channels active, it will come into the cell
- when it comes in, it will bind to the intracellular side and block sodium entry
- called use dependent blockade
- as you continually depolarize neuron, you see continual decrease in sodium currents
|
|
|
Term
Distinct moieties of LA. What is the effect of adding C's or increasing the length of any of these moieties. |
|
Definition
- aromatic portion
- intermediate chain (usually ester or amide)
- amine group (where ionization occurs)
Increasing the number of carbons or length of each of these groups will increase lipophilicity, leading to quickening of onset of action and increased potency. |
|
|
Term
|
Definition
- amides (amide link in intermediate chain)
- lidocain
- mepivacaine
- bupivacaine
- etidocaine
- prilocaine
- ropivacaine
- ester (ester link in intermediate chain)
- cocaine
- procain
- tetracaine
- benzocaine
|
|
|
Term
|
Definition
- short DOA (more prone to hydrolysis)- metabolized by plasma and liver pseudocholinesterases
- more likely to have allergies, because metabolism releases PABA and its derivatives
- toxicity when dose overwhelms capacity of pseudocholinesterases
|
|
|
Term
|
Definition
- longer DOA
- metabolized in the liver by microsomal P450 enzymes
|
|
|
Term
chemistry nature of local anesthetics |
|
Definition
- weak bases- exist in body as uncharged or as cations
- usually has pKa of 7.7-9.1
- means that most of the LA at physiological pH will be in cationic form (about 10 charged:1 uncharged)
- physiological pH = 7 and pKa = 8
- via Henderson Haselback, we know that 8-7=1, which is the log[cationic form/uncharged form]
|
|
|
Term
What is the importance of the chemical nature of anesthetics and its use in areas of infected tissue? |
|
Definition
- we know that the uncharged form is more lipid soluble and therefore better at penetrating membranes
- infected tissue tends to have low extracellular pH
- this means we have more charged form, and less uncharged form
- this leads to poor access, and a LA that is not as effective
|
|
|
Term
What determines the susceptibility of different fibers to local anesthetics |
|
Definition
- fiber diameter- the smaller the diameter, the better the block (due to poor passive conduction) (ex: C fibers)
- myelination- myelinated nerves blocked before unmyelinated nerves. (ex: A fibers)
- firing frequency- the more rapid the firing, the more chance of being blocked (ties into myelination) (ex: A fibers)
- fiber position in the nerve bundle- those deep in bundle harder to access
|
|
|
Term
Relative ability of local anesthetics to block various nerve fibers |
|
Definition
- C fibers the best (due to small diameter)
- A delta fibers second best (due to myelination and faster firing frequency)
- A gamma and beta fibers third best (myelination, faster firing freq. but larger diameter)
- A alpha (myelinated, fastest firing freq., but the largest diameter)
|
|
|
Term
PK of LA: routes of administration |
|
Definition
- injection into area to be blocked
- topical
- infiltration
- Bier block
- peripheral nerve block
- epidural anesthesia
- spinal anesthesia
|
|
|
Term
PK: topical administration (mechanism, examples, location where effective) |
|
Definition
- mechanism- application directly to the surface of area to be anesthetized
- examples
- location- temporary relief for minor procedures at:
- eye
- ear nose
- throat
- dental conditions
|
|
|
Term
PK: infiltration administration (mechanism, examples) |
|
Definition
- mechanism- inject into skin, subQ tissue, mucus membranes in area to be anesthetized
- examples
|
|
|
Term
PK: Bier block administration (mechanism, examples) |
|
Definition
- mechanism
- ensure venous outflow is impeded by a tourniquets
- inject local anesthetics directly into vasculature
- obtain regional anesthesia
- example- lidocaine
|
|
|
Term
PK: peripheral nerve block (mechanism, examples) |
|
Definition
- mechanism
- regional anesthesia
- inject LA into or around nerves in the area to be anesthetized
- block single nerve or plexus
- example
|
|
|
Term
PK: epidural anesthesia (mechanism, example) |
|
Definition
- mechanism- inject into epidural space
- examples
|
|
|
Term
PK: spinal anesthesia (mechanism, examples) |
|
Definition
- mechanism- intrathecal administration
- examples
|
|
|
Term
What determines whether or not there is systemic toxicity? What makes toxicity more likely? |
|
Definition
- probability of toxicity increases when anesthetics administered to tissues with dense vasculature (order of descending vasculature)
- intercostal
- caudal
- epidural
- brachial plexus
- sciatic nerve
- toxicity occurs when local anesthetics are absorbed into the vasculature and reach high enough concentrations to in heart or brain (disrupts cardiac and CNS function)
|
|
|
Term
adverse effects: LA (w/low systemic absorption and high systemic absorption) |
|
Definition
- low systemic absorption: disruption of sensory perception
- high systemic absorption
- brain
- anxiety
- confusion
- tremors
- convulsions
- CV system (except cocaine: HTN, tachycardia, arrhythmia)
- depressed myocardial contractility
- bradycardia
- hypotension
|
|
|
Term
adverse effects of LA: the role of epinepherine |
|
Definition
- role- reduces the likelihood of systemic toxicity
- mechanism of action
- stimulate alpha 1 and vasoconstrict, leading to increased DOA
- stimulate alpha 2 on C fibers, leading to reduction in substance P release, reducing pain transmission (can also use clonidine for this)
|
|
|
Term
adverse effects of LA: upon direct injection into vasculature |
|
Definition
- convulsions
- block GABAA leading to reduced inhibitory neurotransmission
- tx- IV benzodiazepines (ex: diazepam)
- blindness
- aphasia
- hemiparesis
- respiratory depression
- coma
- cardiac arrest
|
|
|
Term
|
Definition
- pain (due to pH of solution)
- ecchymosis (discoloration of skin due to ruptured bv's)
- hematoma
- abscess
- nerve laceration
- tissue necrosis (associated with vasoconstrictor)
|
|
|
Term
cocaine- indications, mechanism of action, unique disadvantage
|
|
Definition
- indication- topically (mucous membrane) in eye surgery
- mechanism- vasoconstrictor
- disadvantage- high abuse potential
|
|
|
Term
procaine (PK, indications) |
|
Definition
- PK
- slow onset
- slow duration of action
- relatively low systemic toxicity
- indications
- infiltration
- nerve block
- epidural
- spinal
|
|
|
Term
lidocaine (PK, other than LA what else is it classified as, unique adverse effect) |
|
Definition
- chemistry- xylidine derivative
- rapid onset
- intermediate DOA
- adverse effect- arrhythmia at high doses
- administered in all six possible forms
Also classified as a 1B antiarrhythmic drug. |
|
|
Term
Ropivacaine (unique advantage and mechanism of that advantage, PK) |
|
Definition
- advantage- low cardiotoxicity
- S isomer only, and this isomer form of LA contributes to reduced cardiotoxicity (normally, R form can block cadiac sodium channels)
- vaoconstriction caused by it reduce spread of drug as well
- PK
- the highest potency
- slow onset of action
- intermediate/long DOA
- administered as:
- infiltration
- nerve block
- epidural
- spinal
|
|
|